Showing results (281-290 of 335) with videos related to
Sort By:
Pageof 34
American Journal of Clinical Oncology|June 11, 2003
Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancersPaul L Schaefer, Randolph S Marks, Michelle R Mahoney, et al.Journal of the American College of Surgeons|April 30, 2013
Current use and surgical efficacy of laparoscopic colectomy in colon cancerRobert P Sticca, Steven R Alberts, Michelle R Mahoney, et al.Journal of Evidence-Based Complementary & Alternative Medicine|June 29, 2014
Patient activation measures in a government homeopathic hospital in IndiaSubhranil Saha, Munmun Koley, E R Mahoney, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapyFrank A Sinicrope, Michelle R Mahoney, Thomas C Smyrk, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcomaM A Dickson, M R Mahoney, W D Tap, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II studySteven R Alberts, William L Horvath, William C Sternfeld, et al.Gastroenterology|June 10, 2004
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndromeMatthew D Coates, Christine R Mahoney, David R Linden, et al.Clinical Colorectal Cancer|July 7, 2011
Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52John S Bolton, Michael J O'Connell, Michelle R Mahoney, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance)Harry H Yoon, David Tougeron, Qian Shi, et al.Cancer|November 24, 2004
Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trialSteven R Alberts, Hani Al-Khatib, Michelle R Mahoney, et al.Pageof 34